Med Dosage 25-36

Usually administered with a β–agonist (albuterol). 500 mcg nebulized

60 mg IM or 30 mg IV (decrease dose by ½ if > 65 y/o)

• Pulseless v-tach/v-fib: 1.5 mg/kg IV push every 3-5 min, maximumdose 3.0 mg/kg
• V-tach with a pulse: 1.0-1.5 mg/kg slow IV push, may repeat at ½ dosein 5-10 min, maximum dose 3.0 mg/kg. If patient is>70 years, has hepatic failure, or CHF decreasesecond dose to ¼ of first dose
• Post conversion: 1-4 mg/min (This is the drip rate established after abolus medication is associated with conversion out ofv-tach or v-fib

0.05 mg / kg IV, max is generally 4 mg

• Cardiac Arrest: 1-2 g IV push
• Cardiac (with pulse): 1-2 g IV, over 5-60 min
• Preeclampsia and eclampsia: 2-4 g IV, over 5-60 min
• Bronchoconstriction: 2 g IV, over 5-60 min

• RSI: 0.1 mg / kg IV, max 10 mg
• Other Sedation/Seizure: 2.5 – 10 mg IV or IM

Asthma/COPD/Allergic reaction: 60-125 mg IV or IM.(Once reconstituted, the mixture is good for up to 48 hr.)

5 mg slow IV, q 5 min x 3 total doses if vitals remain stable

2-5 mg slow IV push, titrated to effect. Max dose usually not to exceed20 mg without OLMC approval. MS can be given IM

0.1–2 mg (IV, IM, SQ, ETT, nasal), repeated to a max of 8 mg.Naloxone shorter acting than most opiates, repeated doses may berequired

1 tablet (0.4 mg) given sublingually q 5 min0.4 mg metered dose spray given sublingually q 5 min, 1-2” paste5 mcg/min IV (titrate up 5 mcg/min every 5 min until desired effect isachieved)

A positive pressure demand valve mask is given to the patient – selfadministered at 50% NO/50% O2. The patient will drop the mask,preventing the induction of anesthesia when unable to hold the maskup any longer